1. Bergh van den ACM, Berg van den G, Schoorl MA et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma; beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Rad Oncol Biol Phys 2007; 67(3): 863-869.
2. Gittoes NJL. Radiotherapy for non-functioning pituitary tumors-when and under what circumstances? Pituitary 2003; 6:103-108.
3. Rodriguez O, Mateor B, Pedraja R et al. Postoperative follow-up of pituitary adenomas after trans-sphenoidal resection: MRI and clinical correlation. Neuroradiology 1996; 38:747-754.
4. Parrott J, Mullins ME. Postoperative imaging of the pituitary gland. Top Magn Reson Imaging 2005; 16:317-323.
5. Bergström M, Muhr C, Lundberg PO et al. PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 1991; 32(4):610-615.
6. Daemen BJG, Zwertbroek R, Elsinga PH et al. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromociptine treatment. Eur J Nucl Med 1991; 18:453-460.
7. Bergström M, Muhr C, Jossan S et al. Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-Deprenyl. Neurosurgery 1992; 30(6):855-861.
8. Tang BNT, Levivier M, Heureux M et al. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Eur J Nucl Med Mol Imaging 2006; 33(2):169-178.
9. Muhr C. Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology 2006; 83:205-210.
10. Ishiwata K, Vaalburg W, Elsinga PH et al. Metabolic Studies with L-[1-14C]Tyrosine for the Investigation of a Linetic model to Measure Protein Synthesis Rates with PET. J Nucl Med 1988; 29:524-529.
11. Vaalburg W, Coenen HH, Crouzel C et al. Amino Acids for the Measurement of Protein Synthesis In Vivo by PET. Nucl Med Biol 1992; 19(2):227-237.
12. Dullaart RP, Pasterkamp SH, Beentjes JA et al. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders; comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test. Clin Endocrinol 1999; 50(4):465-471.
13. Heesters MAAM, Go KG, Kamman RL et al. 11C-tyrosine position emission tomography and 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy. Neuroradiology 1998; 40:103-108.
14. Willemsen ATM, Waarde van A, Paans AMJ et al. In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-Tyrosine and PET. J Nucl Med 1995; 36:411-419.
15. Daemen BJG, Elsinga PH, Paans AMJ et al. Radiation-Induced Inhibition of Tumor Growth as Monitored by PET Using L-[1-11C]Tyrosine and Fluorine-18-Fluorodeoxyglucose. J Nucl Med 1992; 33(3):373-379.